title: Efficacy and safety evaluation of sucrose-formulated recombinant factor VIII for Taiwanese patients with haemophilia A.
authors.forename: J-H
authors.initials: JH
authors.lastname: Young
authors.forename: H-C
authors.initials: HC
authors.lastname: Liu
authors.forename: E-J
authors.initials: EJ
authors.lastname: Hsueh
authors.forename: M-L
authors.initials: ML
authors.lastname: Huang
authors.forename: C-T
authors.initials: CT
authors.lastname: Peng
authors.forename: R-L
authors.initials: RL
authors.lastname: Chen
authors.forename: M
authors.initials: M
authors.lastname: Maas-Enriquez
authors.forename: K
authors.initials: K
authors.lastname: Achilles
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003029:Coagulants / Q000627:therapeutic use*; D005169:Factor VIII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011358:Product Surveillance, Postmarketing; D013395:Sucrose / Q000627:therapeutic use*; D013624:Taiwan; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D003029:Coagulants; C438308:recombinant FVIII, sugar formulated; D013395:Sucrose; D005169:Factor VIII